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Tone-deaf production (A) Mean fundamental frequencies of the two produced tones in tone-deaf listeners. The first tone had a target frequency at a constant 500 Hz, whereas the second tone ranged from 450-550 Hz. (B) Same as A in normal controls. While both groups show a significant positive correlation between target and produced fundamental frequency, the correlation is significantly lower in the tone-deaf group (t(1,10) = 2.3, p = 0.046) and variability in pitch production is higher for the tone-deaf group, as indicated by a t-test comparing standard error across different subjects producing the same pitch: t(1,20) = 3.6, p = 0.0015. Error bars indicate between-subject standard error. Figure 1A and Figure S1 in Supplemental Data, published with this article online). To examine the potential involvement of the MEK-ERK pathway in triggering the oscillatory expression of Hes1, we examined the effects of U0126, a specific MEK inhibitor. Pretreatment with U0126 almost completely inhibited bFGF-induced oscillatory expression of Hes1 ( Figure 1A ). Moreover, pretreatment with another MEK inhibitor (PD98059) or expression of the MAPK phosphatase CL100/MKP1 suppressed the ERK activation and Hes1 oscillation (data not shown). DAPT, an inhibitor of γ-secretase, which cleaves Notch, did not prevent the Hes1 oscillation (data not shown). When U0126 was added to cells 110 min after FGF stimulation, the later rise in hes1 expression was suppressed ( Figure 1C) . Unexpectedly, we then found that ERK phosphorylation, and therefore activity, oscillated in response to FGF stimulation ( Figure 1B,D) . The periodicity of this oscillation in ERK activity was roughly the same as that of Hes1 oscillation, with the ERK oscillation slightly preceding that of Hes1 ( Figure 1E ). ERK activity did not significantly affect the stability of Hes1 protein ( Figure S2 ). ERK activation is therefore required for the FGF-induced oscillatory expression of Hes1 and oscillations in ERK activity may play a role in fine-tuning the Hes1 oscillation.
FGF induces oscillations of
We then found that ERK activity also oscillated in FGF-stimulated NIH 3T3 cells (Figure 2A ,B), with the peak activities being significantly dampened with time. The oscillatory expression of Hes1 was also induced by FGF treatment in NIH 3T3 cells ( Figure S3 ). To investigate the mechanism underlying the oscillation in ERK activity, we then measured Ras activity. To our surprise, Ras activity (Ras-GTP) also oscillated after FGF stimulation (Figure 2A,B) : in contrast to the oscillation of ERK activity, the peak Ras activities were not significantly dampened during the oscillation progression, whereas the trough activities were increased (Figure 2A ). Ras activity also oscillated in FGF-stimulated C3H 10T1/2 cells ( Figure S1 ). We confirmed that our assay method specifically recognizes Ras-GTP ( Figure S4 ). Ras/ERK activities therefore oscillate after FGF stimulation and it is possible that these oscillations may be more striking when assayed at the single-cell level. To examine whether FGF receptor activity is required for oscillations in Ras/ERK activities, we added the specific FGF receptor inhibitor SU5402 to cells 70 min after FGF stimulation and observed suppression of later rises in Ras and ERK activities ( Figure S5 ). We then examined changes in Ras and ERK activities in response to EGF. In HeLa cells, EGF stimulation induced oscillations in Ras activity ( Figure S6 ). These data suggest that the sustained activation of receptor tyrosine kinase is required for oscillations in Ras/ERK activities and that a component(s) common to both FGF and EGF signaling pathways is involved.
As feedback inhibition should underlie oscillatory activation of the signaling pathway [4] , we directed our attention to Sos, the guanine nucleotide exchange factor for Ras. ERK-dependent phosphorylation of Sos results in its dissociation from Grb2 and thus leads to Ras inactivation [5] [6] [7] [8] . Immunoblotting analysis showed that the mobility-shifted bands of Sos protein, which reflect multiple phosphorylation of Sos [8] , oscillated in response to FGF stimulation ( Figure 2C ). It appeared that Sos phosphorylation at 1-10 min resulted in Ras inactivation, and Sos dephosphorylation at 40-60 min led to Ras reactivation ( Figure 2C ). To examine whether ERK activation is sufficient for Ras inactivation, we used ∆B-Raf:ER cells (NIH 3T3 cells expressing the B-Raf kinase domain fused to the estrogen receptor ligand-binding domain) [9] . Induction of B-Raf activation (at -30 min) resulted in sustained ERK activation and Sos phosphorylation and led to almost complete suppression of FGF-induced Ras activation ( Figure S7 ). These results suggest that ERK-mediated phosphorylation of Sos is a cause of Ras inactivation. In fact, when ERK activation was suppressed by U0126, Sos phosphorylation did not occur and Ras activity was sustained at high levels ( Figure 2C) . Moreover, our observation that the peak activity of ERK decreased with time and the trough activity of Ras increased in FGF-stimulated cells (Figure 2A,B) is also consistent with the above idea.
To determine whether ERK-mediated phosphorylation of Sos is required 
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Supplemental data including experimental procedures and supplemental figures are available at http://www.current-biology.com/ cgi/content/full/18/8/R332/DC1 for the oscillations in Ras activity, we used a Sos mutant, Sos-4A, in which the four ERK phosphorylation sites are replaced by alanines [8] , resulting in resistance to ERK-induced dissociation of Sos from Grb2 [8] . When myc-Sos-WT (wild-type) was co-expressed with FLAG-Ras, the Ras activity (FLAG-Ras-GTP) oscillated after FGF stimulation ( Figure 2D ). In contrast, when myc-Sos-4A was co-expressed, the oscillation in Ras activity was abolished, and high levels of Ras activity were maintained ( Figure 2D ), suggesting that the ERK-dependent, negative-feedback phosphorylation of Sos is required for generating oscillations in Ras/ERK activity.
In summary, our results demonstrate that growth factor stimulation induces oscillations of Ras/ERK activities. Although the physiological significance is uncertain at present, oscillatory Ras/ERK activity may act as a novel molecular clock.
